CLINICAL TRIALS PROFILE FOR AZILSARTAN MEDOXOMIL
✉ Email this page to a colleague
All Clinical Trials for AZILSARTAN MEDOXOMIL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00362115 ↗ | Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension | Completed | Takeda | Phase 2 | 2006-05-01 | The purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan medoxomil, once daily (QD), in individuals with hypertension. |
NCT00591253 ↗ | Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension | Completed | Takeda | Phase 3 | 2007-10-01 | The purpose of this study is to evaluate the effectiveness and safety of azilsartan medoxomil compared to placebo, once daily (QD), in African-American participants with essential hypertension. |
NCT00591266 ↗ | Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension | Completed | Takeda | Phase 3 | 2007-10-01 | The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with amlodipine in treating individuals with essential hypertension, compared to treatment with amlodipine alone. |
NCT00591578 ↗ | Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension | Completed | Takeda | Phase 3 | 2007-12-01 | The purpose of this study is to compare the efficacy and safety of TAK-491 (azilsartan medoxomil), once daily (QD), to valsartan in participants with essential hypertension. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AZILSARTAN MEDOXOMIL
Condition Name
Clinical Trial Locations for AZILSARTAN MEDOXOMIL
Trials by Country
Clinical Trial Progress for AZILSARTAN MEDOXOMIL
Clinical Trial Phase
Clinical Trial Sponsors for AZILSARTAN MEDOXOMIL
Sponsor Name